ACTEnact Holdings, Inc.
Is the price fair?
At the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Expensive vs its own history: P/E 10.1 vs a 6.8 median over 20 quarters (+47% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ACT's price assumes
Enact Holdings, Inc. trades at 10.1× earnings against 9.25× for the median Insurance - Specialty name, more expensive than its own group.
Trailing P/E · Insurance - Specialty median 9.25 · 1.09× the median: the market pays up for this one
- Price / sales
- 5.12
Price / sales · as of 2026-Q2
- Price / book
- 1.19
Price / book · as of 2026-Q2
- EV / sales
- 5.31
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.19
- EV / salesas of 2026-Q2
- 5.31
- Financial Services median P/E599 names
- 12.5
- Insurance - Specialty median P/E14 names
- 9.25
- Market capitalisation137.5 million shares, counted Aug 3, 2026
- $6.58B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $24.83 |
| Its own P/E history, median | $32.46 |
| Its own P/E history, upper quartile | $38.77 |
| 52-week range | $34.37 – $50.07 |
| Today | $47.89 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Insurance, Specialty
The closest names by size in the same industry